Clinical Trials Browser

Bile Duct Neoplasms, Breast Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Carcinoma, Medullary

NCT03196518 2025-06-05

Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer

Phase NA Active not recruiting

5 enrolled

Head & Neck

Thyroid Neoplasms

NCT05830838 2025-05-21

DAPPER

Phase NA Active not recruiting

50 enrolled

Genitourinary

Prostatic Neoplasms

NCT01653080 2025-04-11

MRI in Diagnosing Solid Tumors of the Eye and Orbit

Phase NA Active not recruiting

80 enrolled

Eye Neoplasms

NCT01653093 2025-04-11

3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer

Phase NA Active not recruiting

280 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy

PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer

Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer

FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer

Comparing Two Methods to Follow Patients With Pancreatic Cysts

An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma

Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer

Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers

Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer

Diffusion MRI for Head and Neck Cancer

PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study

MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy

CIPN

Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer

DAPPER

MRI in Diagnosing Solid Tumors of the Eye and Orbit

3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer